The Clinical Study of Acute Pancreatitis Treated by TongFuSan

Capital Medical University

Status and phase: Unknown; Phase 2; Phase 1

Conditions: Acute Pancreatitis

Treatments: Drug: TongFuSan

Study type: Interventional

Funder types: Other

Identifiers

NCT02204189

z141100002114004

Details and patient eligibility

About

The purpose of this study is to determine whether TongFuSan is effective in the treatment of acute pancreatitis with gastrointestinal dysfunction.

Full description

• Patient who is diagnosed with acute pancreatitis(AP) should be included.
• Patients will be divided into two groups as random number table: control group(A) and experimental group(B).
• Group A will be given Mosapride po,and group B will be given TongFusan except for basic treatments of AP.
• Same investigator will write the case report form.
• Investigator will collect the patients' blood in three points: on admission, the third day and the seventh day.
• Otherwise, we need write down patients' clinical manifestation,Traditional Chinese Medicine differentiation, the result of clinical tests.
• When the patient discharge, we will write down the treatment measures, therapeutic effect, length of stay and the costs.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• clinical diagnosis of acute pancreatitis，both mild type and severe type

Exclusion criteria

• pregnant or suckling
• cancer in late time
• patient near death

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: Single Blind

---

100 participants in 1 patient group

TongFuSan

Experimental group

Description:

TongFuSan 1g per time, change every day, the duration is seven days

Treatment:

Drug: TongFuSan